Thermo Fisher Scientific

Health biotech life sciences medical diagnostics research

Thermo Fisher Scientific offers biotechnology product development services. The Company focuses on providing laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education.

Revenue(FY, 2017)

$20.9 B

Market capitalization(2018-05-21)

$87.2 B

Customers(FY, 2016)

400 K

Type

Public

Waltham, US

Founded

2006

Size (employees)

70,000 (est)+28%

Website

thermofisher.com

Thermo Fisher Scientific was founded in 2006 and is headquartered in Waltham, US

Report incorrect company information

Key People/Management at Thermo Fisher Scientific

Marc Casper

President and Chief Executive Officer, Thermo Fisher Scientific

Joseph Beery

Senior Vice President and Chief Information Officer

Michael Boxer

Senior Vice President and General Counsel

Lisa Britt

Senior Vice President, Chief Human Resources Officer

Patrick Durbin

Senior Vice President and President, Specialty Diagnostics

Gregory Herrema

Senior Vice President and President, Customer Channels

Report incorrect company information

Thermo Fisher Scientific Office Locations

Thermo Fisher Scientific has offices in Inchinnan, Kuala Lumpur, Versailles, London and in 181 other locations

Waltham, US (HQ)

168 3rd Ave

Inchinnan, GB

3 Fountain Dr

Show all (185)

Report incorrect company information

Thermo Fisher Scientific Financials and Metrics

Thermo Fisher Scientific Financials

Thermo Fisher Scientific's revenue was reported to be $20.92 b in FY, 2017

Summary

USD
Revenue (Q1, 2018)	5.9 b
Net income (Q1, 2018)	579 m
EBIT (Q1, 2018)	786 m
Market capitalization (21-May-2018)	87.2 b
Closing share price (21-May-2018)	216.7
Cash (31-Mar-2018)	950 m

Thermo Fisher Scientific's current market capitalization is $87.2 b.

Source: SEC Filings

Income Statement

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Revenue	13.1 b	16.9 b	17 b	18.3 b	20.9 b
Revenue growth, %		29%	0%	8%
Cost of goods sold	7.6 b	9.4 b	9.2 b	9.9 b
Gross profit	5.5 b	7.5 b	7.8 b	8.4 b

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q3, 2016	Q1, 2016	Q2, 2016	Q1, 2017	Q2, 2017	Q1, 2018
Revenue	3.2 b	3.9 b	4.3 b	4.2 b	3.9 b	4.3 b	4.1 b	4.5 b	4.3 b	4.5 b	4.8 b	5 b	5.9 b
General and administrative expense	848.5 m	1.2 b	1.3 b	1.2 b	1.1 b	1.2 b	1.1 b	1.3 b	1.2 b	1.2 b	1.3 b	1.3 b	1.5 b
R&D expense	95.9 m	149.7 m	183.7 m	175.2 m	165.8 m	174.6 m	171.6 m	183.3 m	176.5 m	182.4 m	215.4 m	221.6 m	234 m
Operating expense total	2.8 b	3 b	4 b	3.5 b	3.4 b	3.7 b	3.6 b	3.9 b	3.8 b	3.9 b	4.1 b	4.2 b	5.1 b

show all

Source: SEC Filings

Balance Sheet

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Cash	5.8 b	1.3 b	452.1 m	786.2 m	1.3 b
Inventories	1.5 b	1.9 b	2 b	2.2 b	3 b
Current Assets	9.9 b	6.5 b	5.7 b	7 b	9.4 b
PP&E	1.8 b	2.4 b	2.4 b	2.6 b	4 b

Quarterly

USD	Q2, 2015	Q3, 2015	Q3, 2016	Q1, 2016	Q2, 2016	Q1, 2017	Q2, 2017	Q1, 2018
Cash	768.4 m	503.4 m	2 b	826.8 m	663.1 m	713.3 m	611 m	950 m
Inventories	2 b	2 b	2.4 b	2.2 b	2.1 b	2.3 b	2.4 b	2.9 b
Current Assets	6.2 b	6 b	8.2 b	6.5 b	6.3 b	7.2 b	7.5 b	9.6 b
PP&E		2.4 b	2.6 b	2.5 b	2.5 b	2.6 b	2.6 b	4.1 b

show all

Cash Flow

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Net Income	1.3 b	1.9 b	2 b	2 b	2.2 b
Depreciation and Amortization					2 b
Inventories	(72.2 m)	(109.8 m)	(140.7 m)	97.8 m	(81 m)
Accounts Payable	47 m	1.2 m	(2.7 m)	55.5 m	274 m

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q3, 2016	Q1, 2016	Q2, 2016	Q1, 2017	Q2, 2017	Q1, 2018
Net Income	931.2 m	543.1 m	821.6 m	1.3 b	385.1 m	896.7 m	1.4 b	1.4 b	402.2 m	918.8 m	551.4 m	1.2 b	579 m
Depreciation and Amortization	750.6 m	365.6 m	800.4 m	1.3 b	416.3 m	836 m	1.3 b	1.3 b	416.1 m	851.2 m	464.5 m	942.7 m	575 m
Inventories	(129.7 m)	(32.1 m)	(53.8 m)	(109.1 m)	(81.3 m)	(122.1 m)	(175.3 m)	22.3 m	(56.2 m)	(25.9 m)	(105.1 m)	(146.1 m)	(124 m)
Accounts Payable	49.1 m	(9.8 m)	3.4 m	(3.3 m)	34.8 m	21.7 m	(26.9 m)	66.1 m	34.8 m	39.9 m	114 m	49 m	(94 m)